Although STXBP1 levels in human patients are unknown, mouse models with a stronger reduction in Stxbp1 levels are desirable to determine to what extent Stxbp1 haploinsufficient mice can recapitulate the neurological phenotypes of STXBP1 encephalopathy. This evidence concerns the gene STXBP1 and Encephalopathy.